Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
Cronos Group announced that Executive Chairman Mike Gorenstein will present at the Canaccord Genuity 41st Annual Growth Conference on August 10, 2021, at 1:30 p.m. EDT. This event will focus on the company’s innovative approach to cannabinoid products and brand development across five continents. A recording will be accessible through the Investors section of the Cronos Group website following the presentation. The company continues to push boundaries in cannabis research and product development, aiming to elevate consumer experiences with its diverse brand portfolio.
- None.
- None.
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Canaccord Genuity 41st Annual Growth Conference on Tuesday, August 10, 2021, at 1:30 p.m. EDT.
A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations.
About Cronos Group Inc.
Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global health and wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™. For more information about Cronos Group and its brands, please visit: www.thecronosgroup.com.
Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the Company's intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, Quarterly Report on Form 10-Q for the period ended March 31, 2021 and Quarterly Report on Form 10-Q for the period ended June 30, 2021, all of which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.
Cronos Group Contact
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
FAQ
What is the date and time of Mike Gorenstein's presentation at the Canaccord Genuity conference?
Where can I watch the recording of the Canaccord Genuity conference presentation by Cronos Group?
What is Cronos Group known for in the cannabinoid industry?
What brands are included in Cronos Group's portfolio?
Is there any forward-looking information in the Cronos Group press release?
